Environment international · 2026
Sub‑chronic PFOA exposure at human‑relevant increasing doses in male mice: Role of stress‑induced gut barrier disruption in shaping intestinal and hepatic responses under high-dose conditions.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bodon Anaïs, Dagès Rémi, Bézirard Valérie, Person Elodie, Stoffels Charlotte B A, Tapias Núria Solà, Bruel Sandrine, Canlet Cécile, Tremblay-Franco Marie, Sovran Bruno, Mselli-Lakhal Laila, Audinot Jean-Nicolas, Cabaton Nicolas, Robert Hervé, Mercier-Bonin Muriel
Аннотация
In humans, dietary intake is thought to be the main route of exposure to perfluorooctanoic acid (PFOA). The gastrointestinal tract is the primary entry point for this highly persistent and bioaccumulative environmental pollutant; however, its fate and effects within the digestive system remain largely unknown. Combining biology-based approaches with mass-spectrometry chemical imaging, our study investigated the impact of 90-day oral exposure to PFOA at a dose relevant to highly exposed human populations on an intact versus stress-impaired gut barrier in adult male mice. A ten-day corticosterone treatment was used to develop an intestinal hyperpermeability model. Unlike this model, exposure to PFOA at 15,000 ng/kg body weight/day did not impair gut barrier integrity nor gut microbiota composition or metabolic functions, when considered separately. However, integrating the 16S metabarcoding and metabolomic datasets revealed subtle yet significant effects of PFOA exposure including a decrease in Lactobacillus, Orodobacter and Ligilactobacillus, as well as changes in short-chain fatty acids (acetate, propionate) and cholic acid. The impact on the liver was determined by simultaneously assessing functional enzymatic activity and mRNA expression of xenobiotic metabolising enzymes. Notably, CYP2C37 activity was inhibited by PFOA exposure under both control and corticosterone conditions. Hepatic homeostasis was also assessed, revealing changes at the transcriptional level in cholesterol transport and biosynthesis pathways, though with no major downstream functional effects. PFOA was found to accumulate in the hepatocyte cytosol as well as in intestinal goblet cells. This work, conducted at human-relevant doses, paves the way for future health risk assessments of PFOA and other substances belonging to the extremely large PFAS family.